2019 Ross Prize in Molecular Medicine — Genomics of Autoinflammatory Diseases
Tuesday, June 4, 2019, 12:30 PM - 5:35 PM EDT
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries have transformed the way medicine is practiced. The awardees are midcareer researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.
The 2019 Ross Prize in Molecular Medicine will be awarded to Dr. Daniel Kastner for the discovery of genetic and genomic strategies to elucidate the molecular basis, and treatment of autoinflammatory diseases.
His discovery of the gene mutated in the inflammatory condition known as Familial Mediterranean Fever, led to the recognition of a motif found in some 20 different human proteins that regulate inflammation. Dr. Kastner's group is also credited with identifying the genomic causes of numerous inherited disorders of inflammation, such as Deficiency of Adenosine Deaminase 2 and Neonatal Multisystem Inflammatory Disease, leading to the establishment of effective therapies for affected patients.
Dr. Kastner maintains a very active clinical research program. Using next-generation sequencing, he continues to discover new disease-causing genes in patients with inflammatory conditions.
Image courtesy of Dr. Liman Zhang, Wu laboratory.
National Institutes of Health
University of Texas Southwestern Medical Center
The University of Edinburgh
Trinity College Dublin
June 04, 2019
Registration and Refreshments
Welcome and Introductory Remarks
Session I: 2019 Ross Prize in Molecular Medicine Presentation and Lecture
2019 Ross Prize in Molecular Medicine Announcement and Presentation
2019 Ross Prize in Molecular Medicine Acceptance
The Systemic Autoinflammatory Diseases: Decoding Innate Immunity One Patient at a Time
Session II: Mechanisms of Innate Immunity and Pro-Inflammatory Disorders
Inflammasomes and Immunometabolism: New Therapies for Inflammatory Diseases
Human Type I Interferonopathies
Immune and Autoimmune Responses to DNA